#Drug_Manufacturing
Comprehensive Seminar on Regenerative Medicine Drug Production and GCTP Compliance#Japan#Tokyo#regenerative_medicine#Drug_Manufacturing#GCTP_Compliance
Comprehensive Seminar on Regenerative Medicine Drug Production and GCTP Compliance
Join the upcoming seminar focusing on the manufacturing process of investigational drugs in regenerative medicine, adhering to GCTP standards.
third-news.com
September 9, 2026 at 3:01 AM
Porton Advanced Achieves Class C Drug Manufacturing License to Boost CDMO Capabilities#China#Suzhou#Porton_Advanced#Drug_Manufacturing#CGT_Solutions
Porton Advanced Achieves Class C Drug Manufacturing License to Boost CDMO Capabilities
Porton Advanced Solutions recently obtained a Class C Drug Manufacturing License, enhancing its capacity for commercial contract manufacturing in the CGT sector.
third-news.com
August 5, 2026 at 12:15 PM
Porton Advanced Solutions Receives Key Drug Manufacturing License to Enhance CDMO Services#China#Suzhou#CDMO_Services#Porton_Advanced#Drug_Manufacturing
Porton Advanced Solutions Receives Key Drug Manufacturing License to Enhance CDMO Services
Porton Advanced Solutions Ltd. has secured a Class C Drug Manufacturing License in China, enabling enhanced services in cell and gene therapy manufacturing.
third-news.com
August 5, 2026 at 11:45 AM
Evonik Injects $100 Million into Advanced Drug Manufacturing Facility in Indiana#USA#Evonik#Lafayette#Drug_Manufacturing
Evonik Injects $100 Million into Advanced Drug Manufacturing Facility in Indiana
Evonik is investing $100 million in its Lafayette, Indiana facility to enhance its drug substance contract manufacturing capabilities, meeting rising demand.
third-news.com
July 8, 2026 at 12:26 PM
Eli Lilly to Invest Over $1.2 Billion in Puerto Rico to Boost Oral Drug Manufacturing#United_States#Puerto_Rico#Eli_Lilly#Carolina#Drug_Manufacturing
Eli Lilly to Invest Over $1.2 Billion in Puerto Rico to Boost Oral Drug Manufacturing
Eli Lilly & Company announces a strategic investment of over $1.2 billion in Puerto Rico, increasing oral drug manufacturing capacity while creating new jobs.
third-news.com
October 29, 2025 at 3:10 PM